Filing Flows › Vycor Medical (VYCO) › Q2 2026 › vs Q2 2025
Vycor Medical (VYCO) Q2 2026 vs Q2 2025 (year over year)
Vycor Medical's revenue fell $78K (-16%) from $496K in Q2 2025 to $418K in Q2 2026. The biggest changes: Vycor Medical Inc −$81K (-17%); NovaVision Inc +$2K (+17%).
Vycor Medical, Q2 2026: revenue $418K (-16% year over year), operating margin 1.6%, net loss $22K, operating cash flow −$5K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Vycor Medical Inc | $401K | $482K | −$81K | -17% |
| NovaVision Inc | $17K | $15K | $2K | +17% |
| Revenue | $418K | $496K | −$78K | -16% |
| Net loss | $22K | −$24K | $46K | — |
| Costs & expenses | $441K | $496K | −$56K | -11% |
| Operating costs | $411K | $445K | −$34K | -8% |
| Interest & other, net | $26K | $25K | $1K | +2% |
| Income tax | $3K | $2K | $1K | +74% |
| Cost of revenue | $74K | $81K | −$7K | -9% |
| SG&A | $323K | $345K | −$22K | -6% |
| Other operating costs | $15K | $15K | $2 | 0% |
| Operating cash sources | $22K | −$42K | $64K | — |
| Depreciation & amortization | $15K | $15K | $2 | 0% |
| Working capital & other | $3K | −$10K | $13K | — |
| Cash used in operations | $5K | −$47K | $51K | — |
| Net loss absorbed | $22K | −$24K | $46K | — |
Questions
How much did Vycor Medical's revenue grow year over year in Q2 2026?
Vycor Medical's revenue fell $78K (-16%) from $496K in Q2 2025 to $418K in Q2 2026.
What drove Vycor Medical's revenue change in Q2 2026?
Vycor Medical Inc −$81K (-17%); NovaVision Inc +$2K (+17%).